MedPath

BLACKMORES (D) LTD

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

3 Phases

Phase 2:2
Phase 3:1
Not Applicable:1

Drug Approvals

384

TGA:384

Drug Approvals

BLACKMORES CONCEIVE WELL GOLD (EXPORT ASIA) (493129)

Product Name
BLACKMORES CONCEIVE WELL GOLD (EXPORT ASIA)
Approval Date
Jun 24, 2025
TGA

BLACKMORES MULTI B (486194)

Product Name
BLACKMORES MULTI B
Approval Date
Apr 16, 2025
TGA

BLACKMORES EXECUTIVE B FORMULA (485714)

Product Name
BLACKMORES EXECUTIVE B FORMULA
Approval Date
Apr 10, 2025
TGA

BLACKMORES KOALAKIDS CALCIGROW (479465)

Product Name
BLACKMORES KOALAKIDS CALCIGROW
Approval Date
Feb 18, 2025
TGA

BLACKMORES OMEGA ULTRA 95 MINI (474728)

Product Name
BLACKMORES OMEGA ULTRA 95 MINI
Approval Date
Dec 24, 2024
TGA

BLACKMORES CONCEIVE GOLD (473686)

Product Name
BLACKMORES CONCEIVE GOLD
Approval Date
Dec 18, 2024
TGA

Blackmores Koalakids Study Buddy Advanced (473606)

Product Name
Blackmores Koalakids Study Buddy Advanced
Approval Date
Dec 17, 2024
TGA

BLACKMORES CONCEIVE WELL MEN (471852)

Product Name
BLACKMORES CONCEIVE WELL MEN
Approval Date
Dec 5, 2024
TGA

BLACKMORES IMMUNE ZINC (468808)

Product Name
BLACKMORES IMMUNE ZINC
Approval Date
Nov 15, 2024
TGA

BLACKMORES KIDS FRUITY FISHIES (468445)

Product Name
BLACKMORES KIDS FRUITY FISHIES
Approval Date
Nov 13, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 39
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (50.0%)
Not Applicable
1 (25.0%)
Phase 3
1 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.